Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. AWK
5. SPCX
6. III
7. TTEC
8. DAL
9. IOVA
10. CHDN

Go back to Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Kala Pharmaceuticals (KALA) Tops Q1 EPS by 19c, Revenues Miss

May 5, 2021 7:23 AM EDT

Kala Pharmaceuticals (NASDAQ: KALA) reported Q1 EPS of ($0.49), $0.19 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $3.27 million versus the consensus estimate of $4.18 million.

We are early in the launch of EYSUVIS and encouraged by our progress... More